Trial intelligence / Profile preview

Effects of atorvastatin on microcirculatory endothelial function in systemic sclerosis

2005-003775-21Phase 4Completed

Sponsor
Northern Care Alliance
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of atorvastatin in systemic sclerosis (SSc), sponsored by Northern Care Alliance. Primary endpoint: Endothelium-dependent vasodilation. Started Nov 2005; status: completed.

02

Drugs

atorvastatin
03

Conditions

systemic sclerosis (SSc)

Beyond the preview

Go deeper on 2005-003775-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003775-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call